Long, G. V., Lipson, E. J., Hodi, F. S., Ascierto, P. A., Larkin, J., Lao, C., Grob, J., Ejzykowicz, F., Moshyk, A., Garcia-Horton, V., Zhou, Z., Xin, Y., Palaia, J., McDonald, L., Keidel, S., Salvatore, A., Patel, D., Sakkal, L. A., Tawbi, H., Schadendorf, D. (2025). Erratum: First-Line Nivolumab Plus Relatlimab Versus Nivolumab Plus Ipilimumab in Advanced Melanoma: An Indirect Treatment Comparison Using RELATIVITY-047 and CheckMate 067 Trial Data. Journal of Clinical Oncology. https://doi.org/10.1200/jco-25-00452